The Homologous single protein target assigned assay, known as DRUGMATRIX, evaluates the inhibition of CYP450, 3A4 enzyme using 7-Benzyloxy-4-(trifluoromethyl)-coumarin as a substrate. The assay employs BTI-TN-5B1-4 cell type and is performed in vitro. The primary function of the assay is to detect binding properties. Does this molecule work well for this assay?